Table 4.

Comparison of patient clinical outcomes among the three groups at the beginning and at the end of the study.

Variable		Control group (mean ± SD)	Phone group (mean ± SD)	Face-to-face group (mean ± SD)	ANOVA
BMI	Preintervention	3.85 ± 28.25	4.06 ± 29.41	4.77 ± 28.27	F (2, 87) = 0.72
					P = 0.48
	Postintervention	3.64 ± 28.71	3.99 ± 29.31	4.67 ± 28.08	F (2, 87) = 0.67
					P = 0.51
FBS (mg/dl)	Preintervention	42.56 ± 147.3	46.7 ± 154.5	50.63 ± 163.76	F (2, 87) = 0.93
					P = 0.39
	Postintervention	38.69 ± 150.9	33.43 ± 138.33	37.65 ± 144.3	F (2, 87) = 0.88
					P = 0.41
Cholesterol (mg/dl)	Preintervention	48.76 ± 167.7	49.52 ± 173.7	52.46 ± 172.5	F (2, 87) = 0.11
					P = 0.88
	Postintervention	49.9 ± 180.23	39.4 ± 154.53	49.4 ± 148.53	F (2, 87) = 3.93
					P = 0.02
Triglyceride (mg/dl)	Preintervention	53.36 ± 162.83	96.12 ± 163.46	69.11 ± 133.9	F (2, 87) = 1.52
					P = 0.22
	Postintervention	53.94 ± 166.63	55.32 ± 132.7	54.81 ± 118.7	F (2, 87) = 6.09
					P = 0.003
HbA1c (%)	Preintervention	1.7 ± 7.8	1.1 ± 8.2	1.5 ± 7.9	F (2, 87) = 0.65
					P = 0.52
	Postintervention	1.5 ± 7.8	1.2 ± 7.3	1.2 ± 7.2	F (2, 87) = 1.56
					P = 0.21